Sarah Mouri

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Re: "Alcohol-related cognitive impairment confounds covert hepatic encephalopathy screening by PHES and the simplified animal naming test" - Brunet et al., clinics and research in hepatology and gastroenterology, 2026.

Re: "Alcohol-related cognitive impairment confounds covert hepatic encephalopathy screening by PHES and the simplified animal naming test" - Brunet et al., clinics and research in hepatology and gastroenterology, 2026.

Journal: Clinics and research in hepatology and gastroenterology

Published: July 30, 2026

Baseline circulating and tumor γδ T cells and early circulating CD8⁺PD1⁺ expansion predict response to Atezolizumab-bevacizumab in HCC.

Baseline circulating and tumor γδ T cells and early circulating CD8⁺PD1⁺ expansion predict response to Atezolizumab-bevacizumab in HCC.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 24, 2026

Corrigendum to 'Pre-emptive TIPS should be considered in high-risk patients with both acute variceal bleeding and severe alcohol-related hepatitis' (JHEP Reports 7 [2025] 101611).

Corrigendum to 'Pre-emptive TIPS should be considered in high-risk patients with both acute variceal bleeding and severe alcohol-related hepatitis' (JHEP Reports 7 [2025] 101611).

Journal: JHEP reports : innovation in hepatology

Published: March 08, 2026

Atezolizumab-bevacizumab in very elderly with hepatocellular carcinoma: Age alone is not a limiting factor except in ALBI grade 3.

Atezolizumab-bevacizumab in very elderly with hepatocellular carcinoma: Age alone is not a limiting factor except in ALBI grade 3.

Journal: JHEP reports : innovation in hepatology

Published: February 16, 2026

Clinical impact of extrahepatic metastatic patterns in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.

Clinical impact of extrahepatic metastatic patterns in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 14, 2026

Clinical predictors of response to Atezolizumab-bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.

Clinical predictors of response to Atezolizumab-bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.

Journal: JHEP reports : innovation in hepatology

Published: December 29, 2025

Clinical predictors of response to atezolizumab/bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.

Clinical predictors of response to atezolizumab/bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.

Journal: JHEP reports : innovation in hepatology

Published: December 29, 2025

Animal naming test at discharge is associated with hepatic encephalopathy after elective TIPS.

Animal naming test at discharge is associated with hepatic encephalopathy after elective TIPS.

Journal: JHEP reports : innovation in hepatology

Published: October 17, 2025

Detection of esophageal varices and prediction of hepatic decompensation in unresectable hepatocellular carcinoma using AI.

Detection of esophageal varices and prediction of hepatic decompensation in unresectable hepatocellular carcinoma using AI.

Journal: Journal of hepatology

Published: October 10, 2025

Detection of Esophageal Varices and Prediction of Hepatic Decompensation in Unresectable Hepatocellular Carcinoma using AI: AI Detection of Varices and Decompensation.

Detection of Esophageal Varices and Prediction of Hepatic Decompensation in Unresectable Hepatocellular Carcinoma using AI: AI Detection of Varices and Decompensation.

Journal: Journal of hepatology

Published: October 10, 2025

Pre-TIPS Liver and Spleen Volumetry Are Not Associated With Liver-Related Outcomes After TIPS Placement for Refractory Ascites.

Pre-TIPS Liver and Spleen Volumetry Are Not Associated With Liver-Related Outcomes After TIPS Placement for Refractory Ascites.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: September 12, 2025

A role for non-selective beta-blockers in preventing liver decompensation in patients with hepatocellular carcinoma undergoing systemic therapy.

A role for non-selective beta-blockers in preventing liver decompensation in patients with hepatocellular carcinoma undergoing systemic therapy.

Journal: Journal of hepatology

Published: August 13, 2025

Showing 1-12 of 32

Last Updated: 09/26/2026